Progress in diagnosis and treatment of ovarian metastases in rectal cancer.
10.3760/cma.j.cn441530-20221110-00460
- Author:
Xue Lai HE
1
;
Qin Xing CAO
2
;
Ming Hui PANG
3
Author Information
1. Department of General Surgery, Chengdu Second People's Hospital, Chengdu 610011,China.
2. School of Medical,University of Electronic Science and Technology of China,Chengdu 611731,China.
3. School of Medical,University of Electronic Science and Technology of China,Chengdu 611731,China Department of Geriatric Surgery,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072,China.
- Publication Type:Journal Article
- MeSH:
Humans;
Female;
Colorectal Neoplasms/pathology*;
Hyperthermia, Induced;
Peritoneal Neoplasms/secondary*;
Rectal Neoplasms/therapy*;
Ovarian Neoplasms/therapy*;
Combined Modality Therapy;
Cytoreduction Surgical Procedures
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(3):295-301
- CountryChina
- Language:Chinese
-
Abstract:
Rectal cancer is the most common tumor of digestive tract. For female patients, ovarian metastasis ranks the second place in intraperitoneal organ metastasis. Its symptoms are occult, easily missed and insensitive to systemic treatment, so the prognosis is poor. Surgery is the treatment of choice for patients with rectal ovarian metastases, whether R0 resection is possible or not, and reducing tumor load is associated with better prognosis. With the continuous development of hyperthermic intraperitoneal chemotherapy (HIPEC), tumor reduction can reach the cellular level, which can significantly improve survival. Prophylactic ovariectomy remains a controversial issue in patients at high risk of ovarian metastasis. In this review, we summarize the diagnosis, treatment and prevention strategies of rectal cancer ovarian metastases, hoping to provide some reference for clinical practice.
